{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:47:33Z","timestamp":1772120853232,"version":"3.50.1"},"reference-count":133,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.iac.2015.12.014","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T08:01:17Z","timestamp":1457424077000},"page":"401-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Novel, Alternative, and Controversial Therapies of Rhinitis"],"prefix":"10.1016","volume":"36","author":[{"given":"Pavol","family":"Surda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wytske J.","family":"Fokkens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.iac.2015.12.014_bib1","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1111\/all.12470","article-title":"Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review","volume":"69","author":"Zuberbier","year":"2014","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/all.12573","article-title":"Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report","volume":"70","author":"Papadopoulos","year":"2015","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/all.12040","article-title":"Uncontrolled allergic rhinitis and chronic rhinosinusitis: where do we stand today?","volume":"68","author":"Hellings","year":"2013","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1183\/09031936.00014614","article-title":"Integrated care pathways for airway diseases (AIRWAYS-ICPs)","volume":"44","author":"Bousquet","year":"2014","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib5","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1185\/03007995.2011.559580","article-title":"Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey","volume":"27","author":"Ciprandi","year":"2011","journal-title":"Curr Med Res Opin"},{"issue":"11","key":"10.1016\/j.iac.2015.12.014_bib6","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/all.12686","article-title":"MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation","volume":"70","author":"Bousquet","year":"2015","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-7022-2-9","article-title":"Explorative study on patient's perceived knowledge level, expectations, preferences and fear of side effects for treatment for allergic rhinitis","volume":"2","author":"Hellings","year":"2012","journal-title":"Clin Transl Allergy"},{"issue":"10","key":"10.1016\/j.iac.2015.12.014_bib8","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1185\/03007995.2013.821055","article-title":"Efficacy, safety, and optimal dose selection of beclomethasone dipropionate nasal aerosol for seasonal allergic rhinitis in adolescents and adults","volume":"29","author":"Raphael","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.iac.2015.12.014_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/JAA.S4051","article-title":"Metabolism of ciclesonide in the upper and lower airways: review of available data","volume":"1","author":"Nave","year":"2008","journal-title":"J\u00a0Asthma Allergy"},{"issue":"10","key":"10.1016\/j.iac.2015.12.014_bib10","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/j.bcp.2007.01.031","article-title":"The role of esterases in the metabolism of ciclesonide to desisobutyryl-ciclesonide in human tissue","volume":"73","author":"Mutch","year":"2007","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib11","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2222.2004.1965.x","article-title":"Topical treatment with aqueous solutions of rofleponide palmitate and budesonide in a pollen-season model of allergic rhinitis","volume":"34","author":"Ahlstrom-Emanuelsson","year":"2004","journal-title":"Clin Exp Allergy"},{"issue":"Suppl 1","key":"10.1016\/j.iac.2015.12.014_bib12","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.2500\/aap.2014.35.3756","article-title":"New intranasal formulations for the treatment of allergic rhinitis","volume":"35","author":"Meltzer","year":"2014","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib13","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1089\/jamp.2014.1180","article-title":"Nasal deposition of HFA-beclomethasone, aqueous fluticasone propionate and aqueous mometasone furoate in allergic rhinitis patients","volume":"28","author":"Leach","year":"2015","journal-title":"J\u00a0Aerosol Med Pulm Drug Deliv"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib14","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1517\/14656566.2015.1020789","article-title":"Advances in pharmacotherapy for the treatment of allergic rhinitis; MP29-02 (a novel formulation of azelastine hydrochloride and fluticasone propionate in an advanced delivery system) fills the gaps","volume":"16","author":"Bousquet","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"1\u20132","key":"10.1016\/j.iac.2015.12.014_bib15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2007.05.014","article-title":"Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index","volume":"275","author":"Schacke","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.iac.2015.12.014_bib16","first-page":"3208","article-title":"Eosinophil as a cellular target of the ocular anti-allergic action of mapracorat, a novel selective glucocorticoid receptor agonist","volume":"17","author":"Baiula","year":"2011","journal-title":"Mol Vis"},{"key":"10.1016\/j.iac.2015.12.014_bib17","first-page":"1515","article-title":"Anti-allergic effects of mapracorat, a novel selective glucocorticoid receptor agonist, in human conjunctival fibroblasts and epithelial cells","volume":"19","author":"Cavet","year":"2013","journal-title":"Mol Vis"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib18","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2005.01.040","article-title":"An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment","volume":"115","author":"Meltzer","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib19","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1517\/14728214.2014.902443","article-title":"Emerging drugs for allergic conjunctivitis","volume":"19","author":"Ridolo","year":"2014","journal-title":"Expert Opin Emerg Drugs"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib20","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.jaci.2013.05.001","article-title":"A\u00a0proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion","volume":"132","author":"Barchuk","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1710-1492-10-33","article-title":"Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit","volume":"10","author":"North","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000329738","article-title":"The efficacy and tolerability of two novel H(1)\/H(3) receptor antagonists in seasonal allergic rhinitis","volume":"158","author":"Daley-Yates","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2015.12.014_bib23","first-page":"967","article-title":"Azines as histamine H4 receptor antagonists","volume":"4","author":"Lazewska","year":"2012","journal-title":"Front Biosci (Schol Ed)"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib24","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.jaci.2006.04.005","article-title":"Anti-IgE as a mast cell-stabilizing therapeutic agent","volume":"117","author":"Chang","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jaci.2003.11.044","article-title":"Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils","volume":"113","author":"Lin","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2015.12.014_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2147\/JAA.S14520","article-title":"Update on optimal use of omalizumab in management of asthma","volume":"4","author":"Pelaia","year":"2011","journal-title":"J\u00a0Asthma Allergy"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaci.2005.09.036","article-title":"Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis","volume":"117","author":"Casale","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2015.12.014_bib28","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.jaci.2007.05.034","article-title":"Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: inhibition of IgE-facilitated allergen binding","volume":"120","author":"Klunker","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib29","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1067\/mai.2002.128804","article-title":"The effect of anti-IgE treatment on in\u00a0vitro leukotriene release in children with seasonal allergic rhinitis","volume":"110","author":"Kopp","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.iac.2015.12.014_bib30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jval.2014.07.009","article-title":"Optimizing the position and use of omalizumab for severe persistent allergic asthma using cost-effectiveness analysis","volume":"17","author":"Faria","year":"2014","journal-title":"Value Health"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib31","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/MCP.0000000000000007","article-title":"Monoclonal antibodies for the treatment of refractory asthma","volume":"20","author":"Hambly","year":"2014","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib32","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1365-2133.2006.07241.x","article-title":"Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5","volume":"155","author":"Murakami","year":"2006","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/194589240201600609","article-title":"Suppression of the Th2 pathway by suplatast tosilate in patients with perennial nasal allergies","volume":"16","author":"Furukido","year":"2002","journal-title":"Am J Rhinol"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib34","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1067\/mai.2001.115624","article-title":"Efficacy of soluble IL-4 receptor for the treatment of adults with asthma","volume":"107","author":"Borish","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9596","key":"10.1016\/j.iac.2015.12.014_bib35","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/S0140-6736(07)61600-6","article-title":"Effect of an interleukin-4 variant on late phase asthmatic response to allergen challenge in asthmatic patients: results of two phase 2a studies","volume":"370","author":"Wenzel","year":"2007","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.iac.2015.12.014_bib36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib37","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/clin.1995.1055","article-title":"T\u00a0cells are necessary for Th2 cytokine production and eosinophil accumulation in airways of antigen-challenged allergic mice","volume":"75","author":"Garlisi","year":"1995","journal-title":"Clin Immunol Immunopathol"},{"issue":"7","key":"10.1016\/j.iac.2015.12.014_bib38","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1164\/rccm.200305-706OC","article-title":"Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice","volume":"169","author":"Leigh","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.iac.2015.12.014_bib39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1067\/mai.2003.169","article-title":"The role of T lymphocytes in the pathogenesis of asthma","volume":"111","author":"Larche","year":"2003","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib40","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1056\/NEJM199201303260504","article-title":"Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma","volume":"326","author":"Robinson","year":"1992","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib41","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.jaci.2006.02.035","article-title":"Toll-like receptor ligands and atopy: a coin with at least two sides","volume":"117","author":"Horner","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1\u20133","key":"10.1016\/j.iac.2015.12.014_bib42","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejphar.2005.12.062","article-title":"Toll-like receptors\u2013novel targets in allergic airway disease (probiotics, friends and relatives)","volume":"533","author":"Feleszko","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"issue":"7","key":"10.1016\/j.iac.2015.12.014_bib44","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.4161\/hv.24631","article-title":"Pollinex quattro: an innovative four injections immunotherapy in allergic rhinitis","volume":"9","author":"Rosewich","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"9","key":"10.1016\/j.iac.2015.12.014_bib45","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1111\/j.1365-2222.2011.03783.x","article-title":"Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study","volume":"41","author":"Klimek","year":"2011","journal-title":"Clin Exp Allergy"},{"issue":"14","key":"10.1016\/j.iac.2015.12.014_bib46","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa052916","article-title":"Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis","volume":"355","author":"Creticos","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib47","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/cpt.157","article-title":"Early clinical evaluation of the intranasal TLR7 agonist GSK2245035: use of translational biomarkers to guide dosing and confirm target engagement","volume":"98","author":"Tsitoura","year":"2015","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.iac.2015.12.014_bib48","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1517\/13543784.2011.583237","article-title":"VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitis","volume":"20","author":"Horak","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.iac.2015.12.014_bib49","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1465-9921-13-53","article-title":"Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis","volume":"13","author":"Greiff","year":"2012","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.molmed.2006.02.005","article-title":"Emerging roles of DP and CRTH2 in allergic inflammation","volume":"12","author":"Kostenis","year":"2006","journal-title":"Trends Mol Med"},{"issue":"7","key":"10.1016\/j.iac.2015.12.014_bib51","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1021\/jm2013997","article-title":"Update on the development of antagonists of chemoattractant receptor-homologous molecule expressed on Th2 cells (CRTH2). From lead optimization to clinical proof-of-concept in asthma and allergic rhinitis","volume":"55","author":"Pettipher","year":"2012","journal-title":"J\u00a0Med Chem"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib52","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nrd2266","article-title":"Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases","volume":"6","author":"Pettipher","year":"2007","journal-title":"Nat Rev Drug Discov"},{"issue":"12","key":"10.1016\/j.iac.2015.12.014_bib53","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.4049\/jimmunol.0804090","article-title":"Novel function of CRTH2 in preventing apoptosis of human Th2 cells through activation of the phosphatidylinositol 3-kinase pathway","volume":"182","author":"Xue","year":"2009","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib54","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jaci.2013.10.013","article-title":"Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis","volume":"133","author":"Krug","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1365-2222.2011.03813.x","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma","volume":"42","author":"Barnes","year":"2012","journal-title":"Clin Exp Allergy"},{"issue":"12","key":"10.1016\/j.iac.2015.12.014_bib56","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1111\/all.12042","article-title":"The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial","volume":"67","author":"Horak","year":"2012","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib57","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000053799","article-title":"Controlled comparison of the efficacy and safety of cetirizine 10 mg o.d. and fexofenadine 120 mg o.d. in reducing symptoms of seasonal allergic rhinitis","volume":"125","author":"Horak","year":"2001","journal-title":"Int Arch Allergy Immunol"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib58","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1185\/03007990802155792","article-title":"Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber","volume":"24","author":"Zieglmayer","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib59","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/jat.1223","article-title":"Pollinex Quattro Ragweed: safety evaluation of a new allergy vaccine adjuvanted with monophosphoryl lipid A (MPL) for the treatment of ragweed pollen allergy","volume":"27","author":"Baldrick","year":"2007","journal-title":"J\u00a0Appl Toxicol"},{"key":"10.1016\/j.iac.2015.12.014_bib60","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.toxicon.2012.10.020","article-title":"Evidence-based review and assessment of botulinum neurotoxin for the treatment of secretory disorders","volume":"67","author":"Naumann","year":"2013","journal-title":"Toxicon"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib61","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.amjoto.2011.01.004","article-title":"Septal injection of botulinum neurotoxin A for idiopathic rhinitis: a pilot study","volume":"33","author":"Braun","year":"2012","journal-title":"Am J Otolaryngol"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib62","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.amjoto.2006.01.008","article-title":"The effect of intranasal injection of botulinum toxin A on the symptoms of vasomotor rhinitis","volume":"27","author":"Ozcan","year":"2006","journal-title":"Am J Otolaryngol"},{"key":"10.1016\/j.iac.2015.12.014_bib63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1746-160X-5-18","article-title":"Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis","volume":"5","author":"Rohrbach","year":"2009","journal-title":"Head Face Med"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib64","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1159\/000055778","article-title":"Minimally invasive application of botulinum toxin type A in nasal hypersecretion","volume":"63","author":"Rohrbach","year":"2001","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"9","key":"10.1016\/j.iac.2015.12.014_bib65","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1080\/00016489.2003.11720744","article-title":"Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial","volume":"123","author":"Unal","year":"2003","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"10.1016\/j.iac.2015.12.014_bib66","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1017\/S0022215100158281","article-title":"The effect of botulinum toxin type A injection for intrinsic rhinitis","volume":"112","author":"Kim","year":"1998","journal-title":"J\u00a0Laryngol Otol"},{"issue":"12","key":"10.1016\/j.iac.2015.12.014_bib67","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1398-9995.2005.00975.x","article-title":"Idiopathic rhinitis, the ongoing quest","volume":"60","author":"van Rijswijk","year":"2005","journal-title":"Allergy"},{"issue":"6 Pt 2","key":"10.1016\/j.iac.2015.12.014_bib68","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/0091-6749(92)90121-H","article-title":"Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa","volume":"90","author":"Baraniuk","year":"1992","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2015.12.014_bib69","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010591.pub2","article-title":"Capsaicin for non-allergic rhinitis","author":"Gevorgyan","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.iac.2015.12.014_bib70","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1046\/j.1365-2222.1997.670842.x","article-title":"Intranasal capsaicin is efficacious in non-allergic, non-infectious perennial rhinitis. A placebo-controlled study","volume":"27","author":"Blom","year":"1997","journal-title":"Clin Exp Allergy"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib71","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1080\/00016480802510186","article-title":"Intranasal Capsicum spray in idiopathic rhinitis: a randomized prospective application regimen trial","volume":"129","author":"Ciabatti","year":"2009","journal-title":"Acta Otolaryngol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib72","first-page":"107","article-title":"Intranasal neuropeptide depletion using topical capsaicin for the control of symptoms in non-allergic, non-infectious perennial rhinitis (NANIPER)","volume":"5","author":"Havas","year":"2002","journal-title":"Aust J Oto Laryngol"},{"issue":"8","key":"10.1016\/j.iac.2015.12.014_bib73","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1034\/j.1398-9995.2003.00203.x","article-title":"Intranasal capsaicin reduces nasal hyperreactivity in idiopathic rhinitis: a double-blind randomized application regimen study","volume":"58","author":"Van Rijswijk","year":"2003","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib74","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.jaci.2013.08.026","article-title":"Capsaicin treatment reduces nasal hyperreactivity and transient receptor potential cation channel subfamily V, receptor 1 (TRPV1) overexpression in patients with idiopathic rhinitis","volume":"133","author":"Van Gerven","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib75","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/bcp.12219","article-title":"Inhibition of capsaicin-driven nasal hyper-reactivity by SB-705498, a TRPV1 antagonist","volume":"77","author":"Holland","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"10.1016\/j.iac.2015.12.014_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009552.pub2","article-title":"Tiotropium versus ipratropium bromide for chronic obstructive pulmonary disease","author":"Cheyne","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib77","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008231.pub3","article-title":"Intranasal ipratropium bromide for the common cold","author":"AlBalawi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib78","first-page":"341","article-title":"Intranasal ipratropium in the treatment of vasomotor rhinitis","volume":"21","author":"Jokinen","year":"1983","journal-title":"Rhinology"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib79","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2273.1983.tb01441.x","article-title":"Ipratropium (Atrovent) in the treatment of vasomotor rhinitis of elderly patients","volume":"8","author":"Malmberg","year":"1983","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib80","first-page":"348","article-title":"A\u00a0trial of intranasal atrovent versus placebo in the treatment of vasomotor rhinitis","volume":"57","author":"Knight","year":"1986","journal-title":"Ann Allergy"},{"issue":"3 Pt 1","key":"10.1016\/j.iac.2015.12.014_bib81","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1164\/ajrccm.162.3.9912055","article-title":"Ipratropium bromide increases the ability of the nose to warm and humidify air","volume":"162","author":"Assanasen","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib82","first-page":"58","article-title":"Common cold and high-dose ipratropium bromide: use of anticholinergic medication as an indicator of reflex-mediated hypersecretion","volume":"35","author":"Ostberg","year":"1997","journal-title":"Rhinology"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib83","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1046\/j.1365-2273.1997.00875.x","article-title":"A\u00a0time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis","volume":"22","author":"Becker","year":"1997","journal-title":"Clin Otolaryngol Allied Sci"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib84","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.jaci.2015.07.038","article-title":"Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study","volume":"136","author":"Schmitt","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib85","doi-asserted-by":"crossref","first-page":"99","DOI":"10.4193\/Rhin12.86","article-title":"Allergen immunotherapy for allergic rhinitis","volume":"51","author":"Petalas","year":"2013","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4193\/Rhin11.268","article-title":"Sublingual immunotherapy in allergic rhinitis: indications, efficacy and safety","volume":"51","author":"Kariyawasam","year":"2013","journal-title":"Rhinology"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib87","first-page":"72","article-title":"Nationwide survey on immunotherapy practice by ENT specialists","volume":"52","author":"Cornelis","year":"2014","journal-title":"Rhinology"},{"key":"10.1016\/j.iac.2015.12.014_bib88","article-title":"Sublingual grass and ragweed immunotherapy: clinical considerations\u2014a PRACTALL consensus report","author":"Li","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2015.12.014_bib89","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/all.12188","article-title":"House dust mite sublingual immunotherapy is safe and appears to be effective in moderate, persistent asthma","volume":"69","author":"Wang","year":"2014","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib90","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1016\/j.jaci.2013.11.012","article-title":"Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis","volume":"133","author":"Bergmann","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.iac.2015.12.014_bib91","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/all.12622","article-title":"Development and evaluation of a sublingual tablet based on recombinant bet v 1 in birch pollen-allergic patients","volume":"70","author":"Nony","year":"2015","journal-title":"Allergy"},{"issue":"8","key":"10.1016\/j.iac.2015.12.014_bib92","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/all.12638","article-title":"Clinical contraindications to allergen immunotherapy: an EAACI position paper","volume":"70","author":"Pitsios","year":"2015","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2015.12.014_bib93","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/all.12560","article-title":"Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma","volume":"70","author":"Maloney","year":"2015","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib94","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1097\/ACI.0000000000000121","article-title":"Novel immunotherapy vaccine development","volume":"14","author":"Jutel","year":"2014","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib95","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/jam.12174","article-title":"Immunotherapy of allergic diseases using probiotics or recombinant probiotics","volume":"115","author":"de Azevedo","year":"2013","journal-title":"J\u00a0Appl Microbiol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib96","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.imlet.2013.12.011","article-title":"Perspectives in vaccine adjuvants for allergen-specific immunotherapy","volume":"161","author":"Fili","year":"2014","journal-title":"Immunol Lett"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib97","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2014.08.006","article-title":"Modulation of dendritic cell innate and adaptive immune functions by oral and sublingual immunotherapy","volume":"155","author":"Frischmeyer-Guerrerio","year":"2014","journal-title":"Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2015.12.014_bib98","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jaci.2014.01.007","article-title":"Immunotherapy: what lies beyond","volume":"133","author":"Casale","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib99","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/all.12278","article-title":"Vitamin D as an adjunct to subcutaneous allergen immunotherapy in asthmatic children sensitized to house dust mite","volume":"69","author":"Baris","year":"2014","journal-title":"Allergy"},{"issue":"9","key":"10.1016\/j.iac.2015.12.014_bib100","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1398-9995.2004.00552.x","article-title":"The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children","volume":"59","author":"Rolinck-Werninghaus","year":"2004","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib101","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4193\/Rhin12.059","article-title":"Septoplasty with concomitant inferior turbinate reduction reduces the need for revision procedure","volume":"53","author":"Karlsson","year":"2015","journal-title":"Rhinology"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib102","doi-asserted-by":"crossref","first-page":"171","DOI":"10.4193\/Rhino14.208","article-title":"The effects of different radiofrequency energy magnitudes on mucociliary clearance in cases of turbinate hypertrophy","volume":"53","author":"Karatas","year":"2015","journal-title":"Rhinology"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib103","doi-asserted-by":"crossref","first-page":"306","DOI":"10.4193\/Rhin13.183","article-title":"Inferior turbinate reduction; coblation versus microdebrider\u2014a prospective, randomised study","volume":"52","author":"Hegazy","year":"2014","journal-title":"Rhinology"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib104","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/lary.24182","article-title":"Which inferior turbinate reduction technique best decreases nasal obstruction?","volume":"124","author":"Larrabee","year":"2014","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4193\/Rhin12.124","article-title":"Respecting nasal mucosa during turbinate surgery: end of the dogma?","volume":"51","author":"Neri","year":"2013","journal-title":"Rhinology"},{"issue":"3","key":"10.1016\/j.iac.2015.12.014_bib106","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4193\/Rhin14.259","article-title":"The effect of \u201cpyriform turbinoplasty\u201d on nasal airflow using a virtual model","volume":"53","author":"Simmen","year":"2015","journal-title":"Rhinology"},{"key":"10.1016\/j.iac.2015.12.014_bib107","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1017\/S0022215100057716","article-title":"Observations on petrosal and vidian neurectomy in chronic vasomotor rhinitis","volume":"75","author":"Golding-Wood","year":"1961","journal-title":"J\u00a0Laryngol Otol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib108","doi-asserted-by":"crossref","first-page":"128","DOI":"10.2500\/ajra.2015.29.4141","article-title":"Surgical management of vasomotor rhinitis: a systematic review","volume":"29","author":"Halderman","year":"2015","journal-title":"Am J Rhinol Allergy"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib109","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1177\/194589240602000216","article-title":"Endoscopic vidian neurectomy","volume":"20","author":"Robinson","year":"2006","journal-title":"Am J Rhinol"},{"issue":"6","key":"10.1016\/j.iac.2015.12.014_bib110","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00405-010-1482-x","article-title":"Endoscopic transsphenoidal vidian neurectomy","volume":"268","author":"Lee","year":"2011","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib111","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3760\/cma.j.issn.0366-6999.20121844","article-title":"Mechanism of traditional Chinese medicine in the treatment of allergic rhinitis","volume":"126","author":"Guo","year":"2013","journal-title":"Chin Med J"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib112","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3342\/ceo.2010.3.4.212","article-title":"Long-term effectiveness and safety of endoscopic vidian neurectomy for the treatment of intractable rhinitis","volume":"3","author":"Jang","year":"2010","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib113","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1017\/S0022215100115622","article-title":"Treatment of 'vasomotor rhinitis' by the local application of silver nitrate","volume":"105","author":"al-Samarrae","year":"1991","journal-title":"J\u00a0Laryngol Otol"},{"issue":"8","key":"10.1016\/j.iac.2015.12.014_bib114","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1017\/S0022215100120614","article-title":"Treatment of allergic and vasomotor rhinitis by the local application of different concentrations of silver nitrate","volume":"106","author":"Bhargava","year":"1992","journal-title":"J\u00a0Laryngol Otol"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib115","first-page":"103","article-title":"Comparison of topical silver nitrate and flunisolide treatment in patients with idiopathic non-allergic rhinitis","volume":"21","author":"Erhan","year":"1996","journal-title":"Tokai J Exp Clin Med"},{"issue":"12","key":"10.1016\/j.iac.2015.12.014_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005235.pub2","article-title":"Inferior turbinate surgery for nasal obstruction in allergic rhinitis after failed medical treatment","author":"Jose","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.iac.2015.12.014_bib117","doi-asserted-by":"crossref","first-page":"591796","DOI":"10.1155\/2013\/591796","article-title":"The anti-inflammatory effects of acupuncture and their relevance to allergic rhinitis: a narrative review and proposed model","volume":"2013","author":"McDonald","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib118","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2500\/ajra.2015.29.4116","article-title":"Acupuncture for the treatment of allergic rhinitis: a systematic review and meta-analysis","volume":"29","author":"Feng","year":"2015","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib119","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.anai.2015.05.017","article-title":"Acupuncture for seasonal allergic rhinitis: a randomized controlled trial","volume":"115","author":"Xue","year":"2015","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib120","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/acm.2008.0471","article-title":"Impact of acupuncture on vasomotor rhinitis: a randomized placebo-controlled pilot study","volume":"15","author":"Fleckenstein","year":"2009","journal-title":"J\u00a0Altern Complement Med"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib121","doi-asserted-by":"crossref","first-page":"e006570","DOI":"10.1136\/bmjopen-2014-006570","article-title":"Effectiveness of moxibustion for allergic rhinitis: protocol for a systematic review","volume":"5","author":"Chen","year":"2015","journal-title":"BMJ Open"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib122","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.anai.2010.11.006","article-title":"Semi-self-administered ear acupressure for persistent allergic rhinitis: a randomised sham-controlled trial","volume":"106","author":"Xue","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib123","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.2500\/ajra.2014.28.4081","article-title":"Ear acupressure for perennial allergic rhinitis: a multicenter randomized controlled trial","volume":"28","author":"Zhang","year":"2014","journal-title":"Am J Rhinol Allergy"},{"issue":"3","key":"10.1016\/j.iac.2015.12.014_bib124","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.jaci.2004.11.005","article-title":"Rhinophototherapy: a new therapeutic tool for the management of allergic rhinitis","volume":"115","author":"Koreck","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2\u20133","key":"10.1016\/j.iac.2015.12.014_bib125","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jphotobiol.2007.09.013","article-title":"Effects of intranasal phototherapy on nasal mucosa in patients with allergic rhinitis","volume":"89","author":"Koreck","year":"2007","journal-title":"J\u00a0Photochem Photobiol B"},{"issue":"2","key":"10.1016\/j.iac.2015.12.014_bib126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3342\/ceo.2013.6.2.73","article-title":"Effects of rhinophototherapy on quality of life in persistant allergic rhinitis","volume":"6","author":"Tatar","year":"2013","journal-title":"Clin Exp Otorhinolaryngol"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib127","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jaci.2007.08.056","article-title":"Intranasal noninhaled carbon dioxide for the symptomatic treatment of seasonal allergic rhinitis","volume":"121","author":"Casale","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.iac.2015.12.014_bib128","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3109\/00016489.2013.861927","article-title":"Kinetic oscillation stimulation as treatment of non-allergic rhinitis: an RCT study","volume":"134","author":"Juto","year":"2014","journal-title":"Acta Otolaryngol"},{"issue":"3","key":"10.1016\/j.iac.2015.12.014_bib129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000381028","article-title":"Nonallergic rhinitis in the elderly: a reliable and safe therapeutic approach","volume":"77","author":"Cantone","year":"2015","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"issue":"1","key":"10.1016\/j.iac.2015.12.014_bib130","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.2500\/ajra.2012.26.3733","article-title":"Crenotherapy modulates the expression of proinflammatory cytokines and immunoregulatory peptides in nasal secretions of children with chronic rhinosinusitis","volume":"26","author":"Passariello","year":"2012","journal-title":"Am J Rhinol Allergy"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib131","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1177\/039463201402700427","article-title":"Nasal cytological assessment after crenotherapy in the treatment of chronic rhinosinusitis in the elderly","volume":"27","author":"Cantone","year":"2014","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"7","key":"10.1016\/j.iac.2015.12.014_bib132","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/lary.25173","article-title":"Olfactory performance after Crenotherapy in chronic rhinosinusitis in the elderly","volume":"125","author":"Cantone","year":"2015","journal-title":"Laryngoscope"},{"issue":"4","key":"10.1016\/j.iac.2015.12.014_bib133","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1177\/039463201102400431","article-title":"Effectiveness of ischia thermal water nasal aerosol in children with seasonal allergic rhinitis: a randomized and controlled study","volume":"24","author":"Miraglia Del Giudice","year":"2011","journal-title":"Int J Immunopathol Pharmacol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856115001253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856115001253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T17:37:34Z","timestamp":1718386654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856115001253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0889856115001253"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2015.12.014","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726305043.793549419","asserted-by":"object"}]},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel, Alternative, and Controversial Therapies of Rhinitis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2015.12.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}